基因疗法当前环境风险评估的科学和实践:一篇综述
1Safe Product Services LLC, Pittsfield, Massachusetts, USA.
Cytotherapy
|May 7, 2024
概括
对基因疗法的环境风险评估 (ERA) 对于监管批准至关重要. 本综述总结了全球法规,并分析了已批准的基因疗法,以澄清ERA内容和安全因素.
科学领域:
- 生物技术是生物技术.
- 环境科学 环境科学
- 监管事务 监管事务
背景情况:
- 基因疗法为遗传疾病和癌症提供了有前途的治疗方法.
- 环境风险评估 (ERA) 对基因疗法开发和监管批准至关重要.
- 欧洲药物管理局评估了药品释放对人类健康和环境的潜在风险.
研究的目的:
- 审查和总结基因疗法的全球法规和内容要求.
- 分析欧盟,美国和日本批准的基因疗法的ERA的关键方面.
- 描述基因治疗中的关键安全因素.
主要方法:
- 对基因疗法的全球监管准则的审查 ERAs.
- 对EMA和FDA批准的基因疗法产品进行环境风险评估的分析.
- 概述这些ERA中的主要内容和关键安全因素.
主要成果:
- 基因疗法ERA遵循临床试验和营销许可的监管指南中概述的一般原则.
- 对批准产品的分析揭示了基因疗法的当前做法和关键方面.
- 确定了基因治疗中使用的关键安全因素和常见的病毒载体.
结论:
- 基因治疗ERA对于确保无意人员,动物,植物,微生物和环境的安全至关重要.
- 随着全球法规的不断发展,基因疗法开发人员需要强大的ERA实践.
- 预计积累的经验将简化基因疗法ERA,特别是涉及常见病毒载体的基因疗法ERA.
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
What is Genetic Engineering?
74.1K
Overview
74.1K
Gene-Environment Interactions
298
Gene expression is a dynamic process that is significantly influenced by environmental factors. This interaction underlies the complex nature of biological development and the phenotypic differences observed among individuals, even among those with identical genetic makeups. Factors such as radiation, temperature, behavior, nutrition, and stress play pivotal roles in determining how genes are expressed. The concept of the reaction range is central to understanding this interaction. It posits...
298
CRISPR
50.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.7K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K


